Blood test could spot Parkinson’s years earlier
pharmaphorum
JUNE 19, 2024
An AI-powered blood test that may be able to predict Parkinson’s years before symptoms develop could allow earlier treatment and guide trials of new treatments
pharmaphorum
JUNE 19, 2024
An AI-powered blood test that may be able to predict Parkinson’s years before symptoms develop could allow earlier treatment and guide trials of new treatments
MedCity News
JUNE 19, 2024
Key questions that must be answered The post Putting Payers in the Driver’s Seat: How the New CMS Interoperability and Prior Authorization is Changing Healthcare appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JUNE 19, 2024
Marea Therapeutics raises $190m for cardiometabolic pipeline, with Santa Ana Bio, Opthea, InduPro, Elion, and iOnctura also completing rounds
PharmaTimes
JUNE 19, 2024
Congenital melanocytic naevus syndrome can cover up to 80% of the bodies of children
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
pharmaphorum
JUNE 19, 2024
Novo Nordisk has been affected by a third fire in a month, the latest involving an office building near its Copenhagen headquarters.
PharmaTimes
JUNE 19, 2024
The serious condition is responsible for approximately 11 million deaths worldwide every year
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
JUNE 19, 2024
Sobi’s long-acting rVIII drug Altuvoct has been cleared for haemophilia A in the EU, with a label that spans all ages and any disease severity.
Pharmaceutical Commerce
JUNE 19, 2024
The latest news for pharma industry insiders.
European Pharmaceutical Review
JUNE 19, 2024
A non-chemotherapy multi-drug therapy enabled complete remission in 38 percent of evaluable patients with aggressive B-cell lymphoma, a Phase Ib/II clinical trial shows. This was observed in individuals who had experienced a return of their cancer or who were unresponsive to standard treatments. Venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) were used together in a treatment regimen in 50 patients with diffuse large B-cell lymphoma (DLBCL).
Pharmaceutical Commerce
JUNE 19, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno, Fran Gregory, PharmD, Vice President of Emerging Therapies, Cardinal Health, discusses what to expect from Cardinal Health's biosimilars pipeline.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
JUNE 19, 2024
IBI-343 is under clinical development by Innovent Biologics and currently in Phase I for Solid Tumor.
pharmaphorum
JUNE 19, 2024
Amazon Pharmacy is expanding its subscription service for generic medicines, making it available to Medicare patients
Pharmacy Times
JUNE 19, 2024
Being able to communicate in a different language can improve treatment adherence and medication efficacy outcomes
Integrity Solutions
JUNE 19, 2024
Why are some salespeople uniquely successful? Do they have some special sales skills that others don’t? If your sales force is somewhat normal, just 20% are high performers. Imagine what a difference it would make if motivating sales teams was tied directly to sales training and increasing their ability develop stronger customer relationships and sell more.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Quantified
JUNE 19, 2024
Executive Summary Artificial Intelligence (AI) is revolutionizing the insurance industry, enhancing customer interactions, risk assessment, and operational efficiency. This report examines AI’s influence on underwriting, predictive analytics, customer service, regulatory compliance, certification training, and the benefits for insurance sales teams.
Pharmaceutical Technology
JUNE 19, 2024
Polaroid Therapeutics’ CEO suggests that pharma should partner with medtech to prevent antibiotic resistance in wound management.
Pharmacy Times
JUNE 19, 2024
Reducing maternal mortality through improving access, screening, education and providing support during pregnancy.
Evolve Your Success
JUNE 19, 2024
Unlock the secrets of simplifying complex medical procedures and fast-track your career in the competitive medical sales industry. In this enlightening episode, we sit down with Josh Reynolds, the Area Vice President of Sales in the Southeast for OrthoFundamentals, to explore the innovative landscape of SI joint fusion. Discover how OrthoFundamentals is redefining industry standards with their streamlined processes and cutting-edge products.
Pharmacy Times
JUNE 19, 2024
Read the Drug Facts Label to Learn More About OTC Medications.
PharmExec
JUNE 19, 2024
Approval of Skyrizi marks the first IL-23 specific inhibitor approved for both ulcerative colitis and Crohn disease of similar severity, according to AbbVie.
PharmaTech
JUNE 19, 2024
PRAC is reviewing the risk of secondary malignancies in patients treated with CAR T-cell medicines.
Pharmaceutical Commerce
JUNE 19, 2024
Deal will target neurological diseases, featuring an initial payment of $42 million for Ascidian and up to $1.8 billion in milestone payments/royalties.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmExec
JUNE 19, 2024
In an interview with Pharm Exec Associate Editor Don Tracy, Pedro Valencia, VP, Solid Tumor Pipeline Strategy & Execution, AbbVie, discusses using novel cancer biomarkers to develop potential first-in-class antibody drug conjugates (ADCs) and the promise that they offer.
Zymewire
JUNE 19, 2024
Master signal-based prospecting to secure your next big clinical trial.
PharmExec
JUNE 19, 2024
The platform will use machine-learning and generative AI to provide insurers with a variety of options and increase automation in their processes.
Pharmaceutical Technology
JUNE 19, 2024
Marea Therapeutics has launched with funding of $190m in a bid to develop cardiometabolic disease treatments.
PharmExec
JUNE 19, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
JUNE 19, 2024
Unither Pharmaceuticals has announced a $106m investment to upgrade its Monroe County facility in New York, US.
PharmExec
JUNE 19, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
JUNE 19, 2024
AbbVie has received FDA approval for SKYRIZI to treat adult patients with moderately to severely active ulcerative colitis.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Let's personalize your content